Institutional investors purchased a net $9.9 million shares of GSK during the quarter ended September 2015, and now own 9.33% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JPMORGAN ASSET MANAGEMENT (UK) L... Bought 3.3 Million shares of GlaxoSmithKline
ARROWSTREET CAPITAL LP Bought 2.2 Million shares of GlaxoSmithKline
T. ROWE PRICE ASSOCIATES, INC. Bought 1.8 Million shares of GlaxoSmithKline